AYUR — Ayurcann Holdings Share Price
0.000.00%
Last trade - 00:00- CA$5.84m
- CA$10.92m
- CA$25.16m
- 56
- 85
- 43
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 35.1 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -41.11% | ||
| Return on Equity | -336.81% | ||
| Operating Margin | -9.31% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 7.63 | 9.39 | 12.49 | 25.16 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ayurcann Holdings Corp. is a Canada-based cannabis licensed producer. The Company specializes in the processing and co-manufacturing of pharma-grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It is primarily concentrating on the recreational market in Canada with proprietary products and formulations including vape carts, pre-rolls, concentrates and extracts. The Company is focused on building a portfolio of brands in the Canadian market, including its flagship mainstream brand Fuego, value brand XPLOR and mainstream brand Happy and Stoned (H&S). Fuego offers various products, including Infused pre-rolls, vapes, Sunny Daze and Night Rider. The Company operates a fully licensed 13,585 square foot extraction and manufacturing facility based in Pickering, Ontario.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 23rd, 2012
- Public Since
- February 2nd, 2011
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 194,703,863
- Address
- 1080 Brock Street, Suite 6, PICKERING, L1W 3H3
- Web
- https://ayurcann.com/
- Phone
- +1 9054923322
- Auditors
- CLEARHOUSE LLP
Upcoming Events for AYUR
Similar to AYUR
Blueberries Medical
Canadian Securities Exchange
C21 Investments
Canadian Securities Exchange
Green Thumb Industries
Canadian Securities Exchange
IM Cannabis
Canadian Securities Exchange
Nass Valley Gateway
Canadian Securities Exchange
FAQ
What is the Ayurcann Holdings share price?
As of Today at 01:28 UTC, shares in Ayurcann Holdings are trading at CA$0.03. This share price information is delayed by 15 minutes.
How has the Ayurcann Holdings share price performed this year?
Shares in Ayurcann Holdings last closed at CA$0.03 and the price had moved by -25% over the past 365 days. In terms of relative price strength the Ayurcann Holdings share price has underperformed the Toronto Stock Exchange 300 Composite Index by -35.13% over the past year.
What are the analyst and broker recommendations for Ayurcann Holdings?
The overall consensus recommendation for Ayurcann Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Ayurcann Holdings dividend yield?
Ayurcann Holdings does not currently pay a dividend.
Does Ayurcann Holdings pay a dividend?
Ayurcann Holdings does not currently pay a dividend.
When does Ayurcann Holdings next pay dividends?
Ayurcann Holdings does not currently pay a dividend.
How do I buy Ayurcann Holdings shares?
To buy shares in Ayurcann Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ayurcann Holdings?
As of the previous close price of CA$0.03, shares in Ayurcann Holdings had a market capitalisation of CA$5.84m.
Where are Ayurcann Holdings shares listed?
Here are the trading details for Ayurcann Holdings:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: AYUR
What kind of share is Ayurcann Holdings?
Based on an overall assessment of its quality, value and momentum Ayurcann Holdings is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ayurcann Holdings share price forecast for 2025?
The analyst consensus target price for shares in Ayurcann Holdings is CA$0.56. That is 1766.67% above the last closing price of CA$0.03.
Analysts covering Ayurcann Holdings currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Ayurcann Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ayurcann Holdings. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -17.57%.
As of the last closing price of CA$0.03, shares in Ayurcann Holdings were trading -27.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ayurcann Holdings PE Ratio?
The Ayurcann Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ayurcann Holdings?
We do not have data on Ayurcann Holdings' directors